ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
Paris-based techbio startup Orakl Oncology raised $34m in Series A funding led by Norrsken VC and Singular. The company intends to scale its AI platform that uses 3D patient-derived tumor organoids to predict cancer treatment responses for colorectal, pancreatic, lung, and gastric cancers.
Tap to vote and see what everyone thinks.
Summary by ByteBrief